首页> 美国卫生研究院文献>Bulletin of the World Health Organization >Third International Reference Preparation of Cardiolipin
【2h】

Third International Reference Preparation of Cardiolipin

机译:第三国际心磷脂参考制剂

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The Third International Reference Preparation of Cardiolipin was produced (in a quantity of 2400 ml) at the WHO Serological Reference Centre, Copenhagen, and assayed in 1957 against the Second International Reference Preparation by four laboratories in three countries. Complement-fixation and slide flocculation tests were used. The new preparation was found acceptable, and its establishment was authorized by the WHO Expert Committee on Biological Standardization.The average log10 titres and results of analyses of variances are shown. The variances were of the usual order of magnitude, and the differences in titre between antigens containing the Second and the Third International Reference Preparations varied from -0.004 to 0.059; only two of the differences exceeded the 5% limit of significance.The use of the Third International Reference Preparation in tests for the acceptability of any new cardiolipin preparation is described.
机译:在哥本哈根的世界卫生组织血清参考中心生产了第三种国际心磷脂参考制剂(2400毫升),并于1957年由三个国家的四个实验室针对第二种国际参考制剂进行了测定。使用补体固定和载玻片絮凝测试。发现新制剂可接受,并且经世卫组织生物标准化专家委员会批准建立,显示了平均log10滴度和方差分析结果。差异通常是一个数量级,含有第二种和第三种国际参考制剂的抗原之间的滴度差异从-0.004到0.059不等。只有两个差异超过了5%的显着性限。描述了在测试任何新的心磷脂制剂的可接受性时使用的第三国际参考制剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号